Gene interfered-ferroptosis therapy for cancers
Improved therapeutic strategies are needed as drug resistance limits the therapeutic efficacy of several clinically approved cancer therapeutics. Here, the authors report a ferroptosis-based therapy using a combination of iron nanoparticles with gene interference to knockdown iron metabolic genes, F...
Guardado en:
Autores principales: | Jinliang Gao, Tao Luo, Jinke Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5464252191f34f768b296b56545dfe08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy
por: Jinliang Gao, et al.
Publicado: (2021) -
Nanoparticles for Ferroptosis Therapy in Cancer
por: Nadia Zaffaroni, et al.
Publicado: (2021) -
Ferroptosis: The Silver Lining of Cancer Therapy
por: Zhengming Tang, et al.
Publicado: (2021) -
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
por: Miele E, et al.
Publicado: (2012) -
Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Kezhen Yi, et al.
Publicado: (2021)